Article
Small Molecules to Elevate Rab7-GTPase Activity and Lower Cholesterol Accumulation in Niemann-Pick Type C Disease.
Pharmaceutical research - 1 Apr 2026
Nguyen Mai K L, Nikenich Maya R, Seifert Kim, Pinkenburg Céline, Lai Felcia, Walther Hanna-Loisa, Hartmann Martje, Szulc Aleksandra, Sparkes Eric, Chen Shihui, Wikramanayake Ravi, Bernaus-Esqué Marc, Liu Yangjing, Tebar Francesc, Serwetnyk Michael, Wenninger Anna, Patzke Christopher, Blagg Brian S J, Ashfeld Brandon L, Groundwater Paul W, Hibbs David E, Hoy Andrew J, Rentero Carles, Enrich Carlos, Cho Ann-Na, Du Jonathan J, Grewal Thomas
Abstract excerpt
PURPOSE: Niemann-Pick type C (NPC) disease caused by mutations in cholesterol transporters NPC1 or NPC2 is characterized by cholesterol accumulation in late endosomes/lysosomes (LE/Lys). The activation of alternative cholesterol export routes that can bypass NPC1/2 deficiency could provide therapeutic opportunities. We previously demonstrated that gene depletion of the Rab7-GTPase activating protein (GAP)...
Topics
Join the communities discussing this publication.
